Alida Biosciences
Biotechnology ResearchSan Diego, United States11-50 Employees
Alida Biosciences is developing the next generation of RNA analysis tools to enable new medical treatments and diagnostic assays.
Innovation in RNA Analysis Alida Biosciences is at the forefront of developing next-generation RNA analysis tools, making it a prime candidate for partners interested in cutting-edge biotech solutions, diagnostics, and personalized medicine.
Strategic Collaborations Recent partnerships with Baylor College of Medicine and DNAnexus highlight opportunities for suppliers and service providers to engage with AlidaBio in expanding its product offerings and research capabilities.
Funding and Growth With a recent $7.5 million Series A funding round and grants from the NHGRI totaling $4 million, AlidaBio demonstrates solid financial backing and growth potential, signaling openness to additional investment and technology collaborations.
Product Diversification The launch of innovative products like the EpiScout Analysis Suite and EpiPlex RNA Library Prep Kit underscores opportunities to sell complementary tools, reagents, and services to enhance their multiplexed RNA analysis platform.
Market Engagement Active participation in industry events such as the Precision Medicine World Conference and collaborations with research institutes position AlidaBio as a strategic partner for organizations seeking advanced RNA analysis solutions aligned with current market trends.
Alida Biosciences uses 8 technology products and services including Google Workspace, Google Fonts API, HubSpot, and more. Explore Alida Biosciences's tech stack below.
| Alida Biosciences Email Formats | Percentage |
| FLast@alidabio.com | 50% |
| FLast@alidabio.com | 50% |
Biotechnology ResearchSan Diego, United States11-50 Employees
Alida Biosciences is developing the next generation of RNA analysis tools to enable new medical treatments and diagnostic assays.
Alida Biosciences's revenue is estimated to be in the range of $10M$25M
Alida Biosciences's revenue is estimated to be in the range of $10M$25M